Cargando…
Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
[Image: see text] We report a detailed investigation into the application of visible light-mediated photocatalysis to a challenging bond construction in a complex pharmaceutical target. The optimized reaction allowed the direct coupling of N-methylmorpholine with an unfunctionalized pyridazine in go...
Autores principales: | Douglas, James J., Cole, Kevin P., Stephenson, Corey R. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260666/ https://www.ncbi.nlm.nih.gov/pubmed/25356724 http://dx.doi.org/10.1021/jo502288q |
Ejemplares similares
-
Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F
por: Ma, L, et al.
Publicado: (2013) -
Synthesis
of (−)-Pseudotabersonine, (−)-Pseudovincadifformine,
and (+)-Coronaridine Enabled by Photoredox Catalysis in Flow
por: Beatty, Joel W., et al.
Publicado: (2014) -
Amine Functionalization via Oxidative Photoredox Catalysis:
Methodology Development and Complex Molecule Synthesis
por: Beatty, Joel W., et al.
Publicado: (2015) -
Preparative semiconductor photoredox catalysis: An emerging theme in organic synthesis
por: Manley, David W, et al.
Publicado: (2015) -
Photoredox Catalysis
in Organic Chemistry
por: Shaw, Megan H., et al.
Publicado: (2016)